The Optimum Strategic Communications Annual Healthcare Investor Conference will take place on Thursday 14th October 2021.
Amber Tong, Senior Editor at Endpoints, chaired a fantastic panel of Europe’s … Continue reading “Takeaways from EU VCs Panel Discussion at Anglonordic Life Science Conference”
Top takeaways from the BSCC – Panel | Investment in Healthcare – where the professionals are investing.
Congratulations to all those listed in InVivo’s list of 30 Rising Leaders … Continue reading “InVivo’s 30 Rising Leaders 2021”
Optimum are proud sponsors of the European Mediscience Awards. Optimum is again … Continue reading “European Mediscience Awards 2021 Short list announced”
Save The Date: 5th – 6th July 2021 speakers from eTheRNA, Lilly, Versameb & Thermo Fisher Scientific will contribute to a panel discussion on ‘mRNA Beyond Vaccine’
To celebrate, we asked the brilliant women in our sector their one main positive to come from the pandemic.
Paul Major, fund manager, BB Healthcare Trust shares his thoughts on the … Continue reading “Vaccines’ Progress: Paul Major Interview”
Optimum supports Anglonordic, the only life science conference in the UK that is exclusively for European investors and R&D companies from the Nordics and the UK to connect with each other.
European innovators helped pave the way for the world’s first COVID-19 vaccines. What’s coming next from Europe’s academic and biotech leaders?
To be credible and investible, ESG is becoming critical to the fund manager’s perspective, as investors shift further to sustainable investment.
February is Heart Awareness Month. In this Insight, Karin Kleinhans of LSP discusses how heart failure, one of the leading causes of death worldwide, is a global problem that demands urgent attention.
Francesco de Rubertis, a co-founder of Medicixi Ventures, has unveiled the next … Continue reading “BioWorld Article by Mike Ward on Medicxi’s launch of Centessa Pharmaceuticals”
CEO Neil Clark and CSO Dr Bill Love from Europe’s leading anti-infectives biotech company Destiny Pharma, on how the makers and influencers of health policy could fuel a renaissance in drug development…
Novo Seeds had a very successful year with five investments. Also, substantial progress has been made across the 25 biotech companies in the portfolio, with 12 drug candidates now in the clinic.
2021: Priorities for European Pharma & What does the investment landscape look like post Covid-19?
From surviving to thriving as 2021 takes the reins from 2020. In a year turned on its head by the pandemic, witnessing this month the unprecedented roll out of a novel coronavirus vaccine, with several more vaccines on the horizon, December has become a time of hope…
Whilst the news is, finally, full of promising updates on vaccines, the world will need a wide range of prophylactic and therapeutic approaches to defeat the coronavirus.
Jonathan Tobin, Managing Director of Arix, talks to Vox Markets
For more information about Optimum Strategic Communications, please get in touch
We'd love to hear from you...GET IN TOUCH